Houamel Dounia, Ducrot Nicolas, Lefebvre Thibaud, Daher Raed, Moulouel Boualem, Sari Marie-Agnes, Letteron Philippe, Lyoumi Said, Millot Sarah, Tourret Jerome, Bouvet Odile, Vaulont Sophie, Vandewalle Alain, Denamur Erick, Puy Hervé, Beaumont Carole, Gouya Laurent, Karim Zoubida
National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France;
National Institute of Health and Medical Research (INSERM) U1149, Research Centre on inflammation, Paris, France; Paris Diderot University, Sorbonne Paris Cité, Paris, France; Laboratory of Excellence, GR-Ex, Paris, France; AP-HP, French Center for Porphyrias, Louis Mourier Hospital, Colombes, France;
J Am Soc Nephrol. 2016 Mar;27(3):835-46. doi: 10.1681/ASN.2014101035. Epub 2015 Aug 20.
The iron-regulatory peptide hepcidin exhibits antimicrobial activity. Having previously shown hepcidin expression in the kidney, we addressed its role in urinary tract infection (UTI), which remains largely unknown. Experimental UTI was induced in wild-type (WT) and hepcidin-knockout (Hepc-/-) mice using the uropathogenic Escherichia coli CFT073 strain. Compared with infected WT mice, infected Hepc-/- mice showed a dramatic increase in renal bacterial load. Moreover, bacterial invasion was significantly dampened by the pretreatment of WT mice with hepcidin. Infected Hepc-/- mice exhibited decreased iron accumulation in the renal medulla and significant attenuation of the renal inflammatory response. Notably, we demonstrated in vitro bacteriostatic activity of hepcidin against CFT073. Furthermore, CFT073 repressed renal hepcidin, both in vivo and in cultured renal cells, and reduced phosphorylation of SMAD kinase in vivo, suggesting a bacterial strategy to escape the antimicrobial activities of hepcidin. In conclusion, we provide new mechanisms by which hepcidin contributes to renal host defense and suggest that targeting hepcidin offers a strategy to prevent bacterial invasion.
铁调节肽铁调素具有抗菌活性。我们之前已证明铁调素在肾脏中表达,因此研究了其在尿路感染(UTI)中的作用,而这在很大程度上仍是未知的。使用尿路致病性大肠杆菌CFT073菌株在野生型(WT)和铁调素基因敲除(Hepc-/-)小鼠中诱导实验性UTI。与感染的WT小鼠相比,感染的Hepc-/-小鼠肾脏细菌载量显著增加。此外,用铁调素预处理WT小鼠可显著抑制细菌入侵。感染的Hepc-/-小鼠肾髓质中铁积累减少,肾脏炎症反应明显减弱。值得注意的是,我们在体外证明了铁调素对CFT073具有抑菌活性。此外,CFT073在体内和培养的肾细胞中均抑制肾脏铁调素,并在体内降低SMAD激酶的磷酸化,提示细菌逃避铁调素抗菌活性的一种策略。总之,我们提供了铁调素有助于肾脏宿主防御的新机制,并表明靶向铁调素提供了一种预防细菌入侵的策略。